No black box warning on record for Flucytosine

As of the latest FDA labeling reviewed, Flucytosine (FLUCYTOSINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Flucytosine medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Flucytosine Capsules USP must be given with extreme caution to patients with impaired renal function. Since Flucytosine Capsules USP is excreted primarily by the kidneys, renal impairment may lead to accumulation of the drug. Flucytosine Capsules USP serum concentrations should be monitored to determine the adequacy of renal excretion in such patients. Dosage adjustments should be made in

No black box warning on record for Flucytosine

Other warnings & precautions

WARNINGS Flucytosine Capsules USP must be given with extreme caution to patients with impaired renal function. Since Flucytosine Capsules USP is excreted primarily by the kidneys, renal impairment may lead to accumulation of the drug. Flucytosine Capsules USP serum concentrations should be monitored to determine the adequacy of renal excretion in such patients. Dosage adjustments should be made in

Flucytosine Black Box Warning

No black box warning on record for Flucytosine

Other warnings & precautions

Flucytosine Black Box Warning

No black box warning on record for Flucytosine

Other warnings & precautions